The FDA pulls key DEI initiative for cancer studies from its website
8 Articles
8 Articles
The FDA pulls key DEI initiative for cancer studies from its website
The Food and Drug Administration has removed webpages about diversity and inclusion in clinical trials for cancer drugs.The page for Project Equity, a 2021 initiative launched by the FDA’s Oncology Center of Excellence to ensure that cancer drugs were evaluated for approval based on data from a diverse group of study participants, has gone dark.The program aimed to develop policies to make clinical trials for treatments more accessible to people…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage